Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2014 ∙ Fortanier, A. C. Venekamp, R. P. Boonacker, C. W. Hak, E. Schilder, A. G. Sanders, E. A. Damoiseaux, R. A.

Pneumococcal conjugate vaccines for preventing otitis media

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2014 ∙ Deloria Knoll, M. Park, D. E. Johnson, T. S. Chandir, S. Nonyane, B. A. Conklin, L. Fleming-Dutra, K. E. Loo, J. D. Goldblatt, D. Whitney, C. G. O'Brien, K. L.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity

  • Newborn
  • Children
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Loo, J. D. Conklin, L. Fleming-Dutra, K. E. Deloria Knoll, M. Park, D. E. Kirk, J. Goldblatt, D. O'Brien, K. L. Whitney, C. G.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Conklin, L. Loo, J. D. Kirk, J. Fleming-Dutra, K. E. Deloria Knoll, M. Park, D. E. Goldblatt, D. O'Brien, K. L. Whitney, C. G.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Fleming-Dutra, K. E. Conklin, L. Loo, J. D. Knoll, M. D. Park, D. E. Kirk, J. Goldblatt, D. Whitney, C. G. O'Brien, K. L.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Sudarsanam, T. D. Tharyan, P.

Vaccines for preventing pneumococcal infection in adults. Summary of the evidence and implications for public health programmes

  • Adolescents
  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ ACIP

ACIP minutes meeting

  • Agenda & Minutes
  • Americas
  • United States of America
  • Pneumococcal disease
Download:
2014 ∙ Conseil Supérieur de la Santé (CSS)

Pneumococcal Vaccine

  • Recommendation
  • Europe
  • Belgium
  • Pneumococcal disease
Download:
2014 ∙ CFV

recommanda- tions visant à prévenir les maladies invasives à pneumocoques chez les groupes à risque

  • Recommendation
  • Europe
  • Switzerland
  • Pneumococcal disease
Download:
2014 ∙ NACI

Update on the Use of Pneumococcal Vaccines: Addition of Asthma as a High-Risk Condition

  • Recommendation
  • Americas
  • Canada
  • Pneumococcal disease
Download:
Loading...